tiprankstipranks
Trending News
More News >
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market
Advertisement

Palvella Therapeutics (PVLA) Income Statement

Compare
638 Followers

Palvella Therapeutics Income Statement

Last quarter (Q1 2024), Palvella Therapeutics's total revenue was $53.00K, a decrease of -97.26% from the same quarter last year. In Q1, Palvella Therapeutics's net income was $-2.54M. See Palvella Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 25.90M$ 31.42M$ 29.32M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 29.05M$ -17.21M
Operating Expenses
$ 14.10M$ 11.87M$ 18.04M$ 79.56M$ 63.24M
Depreciation and Amortization
$ 0.00$ 0.00$ 2.78M$ 2.37M$ 2.13M
EBITDA
$ -13.12M$ 18.69M$ -18.04M$ -43.37M$ -31.61M
Operating Income
$ -14.10M$ -11.87M$ -43.47M$ -51.83M$ -33.92M
Other Income/Expenses
$ -3.34M$ 30.56M$ -10.54M$ 6.09M$ -3.15M
Pretax Income
$ -17.43M$ 18.69M$ -28.58M$ -45.74M$ -37.07M
Net Income
$ -17.43M$ 18.69M$ -27.55M$ -43.37M$ -37.23M
Per Share Metrics
Basic EPS
$ -7.83$ 14.74$ -29.61$ -53.75$ -54.67
Diluted EPS
$ -7.83$ 14.74$ -29.61$ -53.75$ -54.67
Weighted Average Shares Outstanding
2.23M 1.27M 930.35K 806.84K 681.01K
Weighted Average Shares Outstanding (Diluted)
2.23M 1.27M 930.35K 806.84K 681.01K
Currency in USD

Palvella Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis